Cargando…
Binding of the Hepatitis C Virus Envelope Protein E2 to CD81 Inhibits Natural Killer Cell Functions
Infection with hepatitis C virus (HCV) is a leading cause of chronic liver disease worldwide. Little is known about how this virus is able to persist or whether this persistence might be because of its ability to alter the early innate immune response. The major HCV envelope protein E2 has been show...
Autores principales: | Tseng, Chien-Te K., Klimpel, Gary R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2196015/ https://www.ncbi.nlm.nih.gov/pubmed/11781364 http://dx.doi.org/10.1084/jem.20011145 |
Ejemplares similares
-
Inhibition of Natural Killer Cells through Engagement of CD81 by the Major Hepatitis C Virus Envelope Protein
por: Crotta, Stefania, et al.
Publicado: (2002) -
Conformational Flexibility in the CD81-Binding Site of the Hepatitis C Virus Glycoprotein E2
por: Ströh, Luisa J., et al.
Publicado: (2018) -
Dissecting the role of putative CD81 binding regions of E2 in mediating HCV entry: Putative CD81 binding region 1 is not involved in CD81 binding
por: Rothwangl, Katharina B, et al.
Publicado: (2008) -
Recombinant hepatitis C virus-envelope protein 2 interactions with
low-density lipoprotein/CD81 receptors
por: Urbaczek, Ana Carolina, et al.
Publicado: (2015) -
Pseudotyping retrovirus like particles vaccine candidates with Hepatitis C virus envelope protein E2 requires the cellular expression of CD81
por: Soares, Hugo R., et al.
Publicado: (2019)